Excellent
Fully Aligned
Patient Risk:
Low
Summary
The claim is explicitly supported by the label: SOLIRIS increases susceptibility to serious, life-threatening, or fatal meningococcal infections caused by meningococcal bacteria, including Neisseria meningitidis.
Category Scores
Accurate Statements
SOLIRIS increases the risk of serious meningococcal infections caused by Neisseria meningitidis
Supported. Label states SOLIRIS increases susceptibility to serious, life-threatening, or fatal meningococcal infections (septicemia and/or meningitis) caused by meningococcal bacteria, and addresses Neisseria meningitidis (including contraindication for initiation in unresolved serious Neisseria meningitidis infection) in 5.1 and 4.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The statement accurately reflects the labeled risk; it does not omit required safety context for the specific claim.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement